Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Lineage Inc. Reports Second-Quarter 2026 Results

Lineage, Inc. filed a current report on Form 8-K on August 5, 2026, announcing its financial results for the quarter ended June 30, 2026, along with supplemental earnings materials made available on its website.

Shwetambri Chauhan | 05 August 2026

Q32 Bio Reports Q2 2026 Financial Results

Q32 Bio Inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2026, with the U.S. Securities and Exchange Commission, disclosing its financial condition, risk factors, and operational status as a clinical-stage biopharmaceutical company.

Aakashdeep | 05 August 2026

Entrada Therapeutics Files 10-Q for Q2 2026

Entrada Therapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 5, 2026, covering the fiscal quarter ended June 30, 2026.

Aditi Sarkar | 05 August 2026

Kymera Therapeutics Files Q2 2026 Quarterly Report

Kymera Therapeutics, Inc. filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission for the quarterly period ended June 30, 2026, disclosing its financial position and operational status as a clinical-stage biopharmaceutical company.

Anjali Anand | 05 August 2026

Shake Shack Reports Q2 2026 Financial Results

Shake Shack Inc. filed its Form 10-Q with the SEC on August 5, 2026, covering the quarterly period ended July 1, 2026, and reporting Shack sales of $403,437 thousand for the thirteen weeks ended on that date.

Manish Choudhary | 05 August 2026

Latham Group Reports Q2 2026 Financial Results

Latham Group, Inc. filed its quarterly report on Form 10-Q with the SEC on August 5, 2026, covering the fiscal quarter and two fiscal quarters ended June 27, 2026.

Nitish Kishor | 05 August 2026

Rapport Therapeutics Files Q2 2026 Quarterly Report

Rapport Therapeutics, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission, reporting on its financial condition and operations as a clinical-stage biotechnology company.

Manish Choudhary | 05 August 2026

Dine Brands Global Files Q2 2026 Form 10-Q

Dine Brands Global, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 5, 2026, covering the fiscal quarter ended June 28, 2026.

Nitish Kishor | 05 August 2026

Lakeland Financial Posts Q2 2026 Earnings Results

Lakeland Financial Corporation, a Indiana-based bank holding company trading on the Nasdaq Global Select Market as LKFN, filed its Form 10-Q for the quarterly period ended June 30, 2026, on August 5, 2026, disclosing net income, balance sheet changes, and income statement details for …

Anjali Anand | 05 August 2026

NCR Voyix Posts Q2 2026 Results in 10-Q Filing

NCR Voyix Corporation (NYSE: VYX) filed its quarterly report on Form 10-Q for the period ended June 30, 2026, disclosing revenue, earnings, and balance sheet data for the three and six months ended June 30, 2026.

Aakashdeep | 05 August 2026
Support

Hi! How can we help you today?

Loading…